title: Fulminating hydralazine-induced lupus pneumonitis.
authors.affiliation: Hospital for Joint Diseases, New York University School of Medicine, New York, USA.
authors.forename: Belinda
authors.initials: B
authors.lastname: Birnbaum
authors.forename: Gurdip S
authors.initials: GS
authors.lastname: Sidhu
authors.forename: Robert L
authors.initials: RL
authors.lastname: Smith
authors.forename: Michael H
authors.initials: MH
authors.lastname: Pillinger
authors.forename: Clement E
authors.initials: CE
authors.lastname: Tagoe
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects*; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000473:pathology; D013902:Radiography, Thoracic; D014057:Tomography, X-Ray Computed
chemical_list: D000959:Antihypertensive Agents; D006830:Hydralazine